Recall Record

Hauppauge, NY, United States

Marksans Pharma Inc. recalls

3 recalls recorded since 2018, most recently on 2 October 2020. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0

Terminated Class II Drugs

Recall started
2 October 2020
Terminated
21 February 2024
Reason
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0061-2021, D-0062-2021

Terminated Class II Drugs

Recall started
5 June 2020
Terminated
7 September 2023
Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-1356-2020

Terminated Class II Drugs

Recall started
9 January 2018
Terminated
26 May 2020
Reason
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Distribution
Distributed to repackaging firms in NY who then distributed Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0239-2018, D-0235-2018, D-0240-2018, D-0237-2018, D-0236-2018, D-0238-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.